A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus

Clinical trial NCT03161483 · COMPLETED

Trial details

NCT number: NCT03161483
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic

Start date: 2017-08-31
Primary completion: 2021-08-03
Enrollment: 289

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.